IκBζ is a key player in the antipsoriatic effects of secukinumab.
Bertelsen T, Ljungberg C, Litman T, Huppertz C, Hennze R, Rønholt K, Iversen L, Johansen C.
Bertelsen T, et al.
J Allergy Clin Immunol. 2020 Jan;145(1):379-390. doi: 10.1016/j.jaci.2019.09.029. Epub 2019 Oct 14.
J Allergy Clin Immunol. 2020.
PMID: 31622687
Free article.
Clinical Trial.